zoledronic acid has been researched along with Sclerosis, Systemic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balbir-Gurman, A; Bank, I; Braun-Moscovici, Y; Fisch, P; Migalovich Sheikhet, H; Villacorta Hidalgo, J | 1 |
1 other study(ies) available for zoledronic acid and Sclerosis, Systemic
Article | Year |
---|---|
Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
Topics: Adult; Aged; Cardiolipins; Cells, Cultured; Cytokines; Diphosphonates; Female; Humans; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Male; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta; Scleroderma, Systemic; T-Lymphocyte Subsets; Zoledronic Acid | 2018 |